Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
Yahoo
Mon, 04/25/16 - 06:39 pm
Tags:
AbbVie, FDA, Viekira Pak, hepatitis C
AbbVie Inc (ABBV) Q1 Earnings: Here’s What to Expect
Bidness, ETC
Mon, 04/25/16 - 09:27 am
Tags:
AbbVie, earnings
Goldman Sach's 5 Large-Cap Pharma Stock Favorites Ahead of Earnings
TheStreet.com
Mon, 04/25/16 - 08:06 am
Tags:
earnings, Bristol-Myers Squibb, AbbVie, Allergan, Teva Pharmaceutical, Mylan
AbbVie Strikes Two Cancer Collaborations: Smart Move?
Bidness, ETC
Fri, 04/22/16 - 11:05 am
Tags:
AbbVie, cancer, Argenx, ARGX-115, CytomX, probodies
AbbVie and CytomX Announce Strategic Collaboration for Probody Drug Conjugates
Yahoo
Fri, 04/22/16 - 10:37 am
Tags:
AbbVie, CytomX, probodies, R&D, cancer, CD71
AbbVie trade sees support after earnings
Yahoo/OptionMonster
Tue, 04/19/16 - 06:15 pm
Tags:
AbbVie, earnings
AbbVie's experimental hep c combo proves highly effective across genotypes
BioPharma Dive
Mon, 04/18/16 - 04:27 pm
Tags:
AbbVie, hepatitis C, ABT-493, ABT-530
How AbbVie Plans To Replace Humira
Seeking Alpha
Tue, 04/12/16 - 07:43 am
Tags:
AbbVie, Humira, R&D, autoimmune disease, ABT-122, ABT-494, ABBV-247, ALX-0061
AbbVie wins FDA approval for leukemia drug
BioPharma Dive
Mon, 04/11/16 - 05:22 pm
Tags:
AbbVie, FDA, Venclexta, CLL, Genentech
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
Tags:
AstraZeneca, ZS-9, Relypsa, Veltassa, Synergy Pharmaceuticals, plecanatide, Linzess, Ironwood, Allergan, Incyte, Eli Lilly, baricitinib, AbbVie, Humira
Samsung brings in the lawyers for biosimilars push
Yahoo/Reuters
Mon, 04/4/16 - 07:54 am
Tags:
Samsung Bioepis, AbbVie, biosimilars, Humira
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
Wed, 03/23/16 - 04:23 pm
Tags:
ViiV Healthcare, Pfizer, GSK, Shionogi, AbbVie, Lundbeck, Janssen, Novo Nordisk
AbbVie’s Therapies in Virology, Neurology, and Women’s Health
Yahoo/Market Realist
Wed, 03/16/16 - 09:58 am
Tags:
AbbVie, virology, neurology, Women's Health
VA to stop restricting hep C drugs, offering them to all infected veterans
Fierce Pharma
Sun, 03/13/16 - 01:13 pm
Tags:
Veterans Administration, hepatitis C, Gilead Sciences, AbbVie
Should AbbVie Fear Sanofi-Regeneron Drug Trial Data?
Bidness, ETC
Sat, 03/12/16 - 09:41 am
Tags:
AbbVie, Sanofi, Regeneron, clinical trials, Sarilumab, Humira, biosimilars, rheumatoid arthritis
Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial
Bloomberg
Fri, 03/11/16 - 11:51 am
Tags:
Sanofi, AbbVie, Humira, clinical trials, Sarilumab, rheumatoid arthritis
AbbVie's Humira, Pfizer's Lyrica kick off 2016 with hefty TV ad spend
Fierce Pharma Marketing
Thu, 03/10/16 - 09:28 pm
Tags:
AbbVie, Humira, Pfizer, Lyrica, drug ads
What Abbvie’s Latest Deal Means For The Company
Bidness, ETC
Tue, 03/8/16 - 06:13 pm
Tags:
AbbVie, R&D, Boehringer Ingelheim
AbbVie to Pay $595 Million for Boehringer Immunology Treatments
Bloomberg
Mon, 03/7/16 - 09:33 am
Tags:
AbbVie, Boehringer Ingelheim, M&A, psoriasis, Crohn’s disease, asthma
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
Fierce Pharma
Sat, 03/5/16 - 09:50 am
Tags:
JNJ, AbbVie, Imbruvica, CLL, FDA, chronic lymphocytic leukemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.